OBJECTIVE - To evaluate the implementation of a novel algorithm-based discharge programme for the community follow-up of men with prostate cancer.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
MATERIALS AND METHODS - Men with prostate cancer considered suitable for discharge were identified from consultant-led and clinical nurse specialist telephone clinics at Nottingham University Hospitals NHS Trust.
Patients were discharged on to one of four discharge pathways: watchful waiting, androgen deprivation therapy (ADT), post-prostatectomy and post-radiotherapy. Primary care providers were asked to adhere to specific surveillance measures and refer patients back to secondary care following breach of pre-defined PSA threshold criteria. Reasons for non-compliance, re-referral and cause of death were determined for all discharged men.
FINDINGS - 573 men were discharged across all four pathways; 169 on the watchful waiting pathway, 229 on the ADT pathway, 95 on the post-prostatectomy and 80 on the post-radiotherapy pathway. All patients had a minimum 12 months follow-up. 48 of 54 (88. 9%) of men were re-referred promptly following PSA-threshold breach. Of the remaining six patients there were three refusals, one unrelated death prior to referral and two late referrals at four months. Three patients were lost to follow-up due to database non-registration and were subsequently recalled, none of whom with a PSA-threshold breach. There were three unexpected deaths attributed to prostate cancer: two were community deaths with no biochemical or clinical evidence of prostate cancer progression; one was due to a likely progressive PSA non-secreting tumour.
INTERPRETATION - Initial results suggest the algorithm-based protocol is a viable, effective and oncologically safe method for the controlled discharge of men from secondary to primary care. Longer-term follow-up, patient satisfaction and cost-effectiveness data are required to assess the true impact of the initiative. This article is protected by copyright. All rights reserved.
BJU international. 2016 Feb 15 [Epub ahead of print]
Philip P Goodall, Jessica Little, Eleanor Robinson, Ian Trimble, Owen J Cole, Thomas J Walton
Department of Urology, Nottingham University Hospitals NHS Trust. , Department of Urology, Nottingham University Hospitals NHS Trust. , Department of Urology, Nottingham University Hospitals NHS Trust. , Nottingham City Clinical Commissioning Group. , Royal Guernsey Hospital, Guernsey. , Department of Urology, Nottingham University Hospitals NHS Trust.